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Insulin-like growth factors I and II (IGF I and II) are polypeptides with both growth-promotin$ and insulin-like metabolic effects 16"27. 
Immunorea~ive IGF I is present in the retina t4 and both IGF I and II are present ~ vitreal fluid 12. The type I and type II IGF receptors 
are a~o localized withi~ the neural retina 3a5"2°'33. The presence of IGFs and IGF receptors within the eye suggests a possible growth-pro- 
motir~g e~f~.ct of IGFs on ocular tissues. IGF may enter the eye from the blood or, ~iternatively, arise from an ocular cell type which syn- 
thesizes and secretes IGF. IGF I and II mRNA synthesis in scleral ceils ~3 and IGF I synthesis in rat retina 14 suggests endogenous IGF pro- 
ductit~n in the eye. We hypothesized that IGFs and IGF receptors are synthesized by one ocular cell type, the retinal pigment-epithelium 
(RPE). As a first step in studying IGF production by the RPE, we analyzed expression of the IGF and IGF receptor genes by cultured 
human RPE cells. Using Northern analysis, RNase protection and reverse-transctSptase polymerase chain reaction (RT-PCR), we found that 
cultured RPE cells synthesize mRNA for IGF I and the type I and type 1I IGF receptors. 
INTRODUCTION 
Insulin-like growth factors I and II (IGF I a r d  IGF  
II) are polypeptides which share structural homology 
with proinsulin and exert mitogenic and growth-promot- 
ing effects in many tissues 16'27. IGF I and IGF II bind 
to specific membrane receptors, the type I and type II 
IGF receptors, respectively 7'22'~. In the eye, autoradiog- 
raphy ;,2°, immunocytochemistry 2° and affinity labelling 15' 
2o.33 have localized both the type I and II IGF receptors 
to the neural retina and retinal pigment epithelium 
(RPE).  IGF I and II immunoreactivity are present in the 
vitreous n ,  whereas only IGF  I immunoreactivity is 
present in the retina and R P E  u .  Because the RPE,  lo- 
cated adjacent to the choriocapillaris, is responsible for 
the active transport of ions, metabolites and fluid to the 
inner retina 37, IGF I immunostaining may reflect R P E  
internalization of circulating IGFs. Alternatively, IGF I 
immunoreactivity could reflect endogenous growth fac- 
tor production. In vitro conditioned medium from cul- 
tured human RPE contains I G F  I immunoreact-ivitv 34, 
implying either release of internalized IGF I, as seea in 
endothelial cell cultures 2, or  endogenous IGF I produc- 
tion by RPE.  
As an initial approach to understanding whether ocu- 
lar IGF I and II represent internalized or newly synthe- 
sized growth factors, we determined whether cultured 
human RPE cells express th~ genes for IGF I and II and 
their receptors. Because there are differences in the sen- 
siti,Aty of various assays and we were interested in the 
relative gene expression levels, we used three indepen- 
dent methods to assay levels of cellular mRNAs for the 
IGF and IGF receptor genes: Northern analysis, ribcnu- 
clease (RNase) protection and reverse-transcriptase poly- 
merase chain reaction (RT-PCR),  listed in order of in- 
creasing sensitivity t7,26. Using these methods, we have 
detected IGF I, type I and type II IGF receptor m R N A  
in cultured human RPE cells. Our  data provide a basis 
for analyzing the regulation and expression of these genes 
in human RPE cells, a key cell type in ocular health and 
disease. 
MATERIALS AND METHODS 
Chemicals 
Minimum essemial medium (MEM) and PJ'MI 1640 medium 
were purchased from Grand Island Biological Co. (Grand Island 
NY). Improved minimum essential medium (IMEM) was obtained 
~ora Biofiuids (RockviUe, MD) and bovine calf serum (CS) from 
Hycione Labs (Logan, Lrl'). Tissue culture supplies were purchased 
from Costar (Cambridge, MA) and Coming Glass Works (Corn- 
ing, NY) Molecular biology grade reagents were purchased from 
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Sigma. All other chemicals were of reagent grade and obtained 
from Baker Chemical Co. (Phillipsburg, N J) or Fisher Scientific 
(Fairhave~, N J). 
Cell c:~lture 
Retinal pigment epithelia were isolated from human post-mor- 
tem eyes provided by the Michigan Eye Bank. Primary RPE cell 
cultures were estabfished as previously described s. Cells were pe- 
riodically subcuitured at a density of 3-5 x 106 cells per 75 cm 2 
tissue culture flask in MEM containing 20% CS. Ceils were main- 
tained at 37 °(3 in a humidified atmosphere of 5% CO2 and 95% 
0 2. Medium was changed 3 times weekly. 
Breast cancer cell line MD,~-MB231 was obtained from Ameri- 
can Type Culture Collection (ATCC, Rockville, MD) and main- 
tained in IMEM with 10% CS. The human neuroblastoma cell line 
SK-N-SH was obtained from J. Biedler, Memorial Sloan-Kettering 
Institute (New York, NY) and maintained in RPMI 1640 medium 
with 10% fetal CS. 
Northern analysis 
Total cellular RNA was isolated from cells or tissues by guani- 
dinium thiocyanate-phenol extraction s. Poly(A) + and poly(A) 
RNA were selected by oligo(dT) cellulose chromatography follow- 
ing the manufacturer's protocol (Pharmacia, Gaithersburg, MD) 1. 
The hut, ran IGF IA cDNA was kindly provided by Dr. Peter S. 
Rotwein (Washington University School of Medicine, St. Louis, 
MO) 24. An 818-base pair (bp) region of IGF IA cDNA encoding 
exons i, 2, 3 and 5 was excised from pBlueScript KS (Stratagene, 
La Jolla, CA) by digestion with EcoRI (Stratagene, La Jolla, CA). 
The cDNA for human IGF II was kindly provided by Dr. Graeme 
I. Bell (Howard Hughes I~stitme, Chicago, IL) 4. An 854-bp region 
of IGF II cDNA enco~lin~ exons 7, 8 and part of 9 was excised 
from pGEM4 (Promega, Madison, WI) by digestion with Pstl. 
Type I IGF receptor eDNA was obtained from Dr. Axel Ullrich 
(Max Planck Institute, Munich, F.R.G.) 32. A 1247-bp insert encod- 
ing part of the type I IGF receptor a and fl chains was excised by 
digestion of pGem4 with EcoRI and HindIII (Stratagene, La Jo!!a, 
CA). All templates were 32p.labelled by random priming (Amer- 
sham, U.K.) for use in hybridization reactions. 
RNA samples (1-10/~g) were d.;ssolved in 37.5% formamide, 1.6 
M formaldehyde and 1.5 mM sc, dium phosphate buffer. RNA sam- 
ples were electrophoresed in denaturing gels (1% agarose, 2.2 M 
formaldehyde, 0.02 M sodium phosphate buffer) and transferred to 
Nytran nylon membranes (Schleicher & Schuell, Keene, NH) by 
capifiary blotting. After transfer, 40-100 ng of denatured IGF I and 
IGF II cDNA were applied to the membrane for positive and neg- 
ative hybridization efficiency controls. Nucleic acids were baked 
o~to membranes for 30 min at 65-80 °C. Membranes were hybrid- 
ized in 40% formamide, 1.1 M NaCl, 60 mM NaH2PO4, 6 mM 
EDTA, 1.0% sodium dodecyl sulfate (SDS), 10% dextran sulfate, 
100-200/~g/ml denatured salmon DNA and 32p-labeUed cDNA 
probe (I-5 × I05 cpm/mi) for 12-16 h at 42 °C. Membranes were 
washed twice for 15 min in 0.36 M NaCI, 20 mM NaH2PO4, 2 mM 
EDTA and 0.1% SDS at room temperature and twice for 15 min at 
65 °(3 in 90 mM NaCl, 5 mM NaH2PO4, 0.5 mM EDTA and 0.1% 
TABLE I 
Primers used in the RT.PCR assay 
Gene Primers used Lo. Product Re£ 
cation size 
IGF-I TCACATCTCTrCTACCTGGC Exon 2 
GTAGGTCTI'GTI'I'CCTGCAC Exon 5 366 bp 
IGF-II GAGTGCTGCTrCCGCAGCTG Exon 3 
TCTCTGAACGCTrCGAGCTC Exon 4 249 bp 
28 
SDS. For high stringency, membranes were washed twice for 15 
min at 65 °(3 in 18 mM NaCI, 1 mM NaH2PO 4, 0.1 mM EDTA 
and 1.0% SDS. Membranes were exposed to X-ray film (Kodak) in 
the presence of an intensifying screen at -70 °(3 for 1-7 days. 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
One/~g of total cellular RNA was transcribed into complimen- 
tary DNA. Briefly, in a 20/d volume of 1 x PCR buffer (Pe~kin 
Elmer Cetus, Norwalk, CT), 1 mM each dNTP (Sigma), 1 Ul/d 
RNAsin (Boehringer-Mannheim, Indianapolis, IN), 100 pM ran- 
dom hexamer (Sigma) and 200 U of Moloney MuLV reverse tran- 
scriptase (Bethesda Research Labs, Bethesda, MD) were added to 
1/~g of total cellular RNA (or water for control samples) and in- 
cubated for 60 min at 42 °(3. The reaction was hea~-inactivated at 
95 °(3 for 5 min, then placed on ice. To each 20/d reaction, 8/d 
10x PCR buffer, 69/A sterile H20, 1/d each of an upstream and 
downstream primer and 1/d of I U//A Taq DNA pol~merase (Per- 















Fig. 1. A: IGF I exon 3 R~ase protection assay in human cultured 
RPE cells. An antisense RNA probe was transcribed from ~ 1-kb 
segment of the IGF I gene that contained 182-bp of exon 3. Liver 
RNA protected the appropriate sized fragment, while RPE RNA 
did rot. Radiograph exposed 36 h. B: IGF II RNasc protection as- 
say in cultured human RPE cells. An 854-bp IGF ~I cDNA ob- 
tained from human liver was used as a probe template. RPE ~id 
not protect this probe, while the neuroblastoma cell line SK-N-SH 
protected an expected 580 bp. Radiograph exposed 48 h. 
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mal cycler for 40 cycles, using the PCR cycle profile recommended 
by the Taq DNA polymerase manufacturer. The sequences of oli- 
gonucleotide primers used are outlined in Table I. Primers were 
constructed to conserve regions between rat and human sequences ~' 
~.=. To eliminate the possibility of DNA contamination, primers 
spanned intronic sequences ~'~. After PCR, 20/d afiquots were 
electrophoresed in a 1% agarose gel containing 0.4/~g/n~! etMdium 
bromide in 1 × TBE buffer as described ~9. 
RNase p~otection assay 
All riboprobes were synthesized from cDNA templates accord- 
ing to the manufacturer's protocol (Promega, Madison, WI). An 
exon 3 genon~c IGF 1 fragment was provided by Dr. Peter Rot- 
wein 24. An 854-bp EcoRI-EcoRl IGF II cDNA fragment was pro- 
vided by Dr. Graeme L Bell (Howard Hughes Institute, Chicago, 
IL) 4. A 293-bp Aval-A~,aI fragment of type I IGF receptor cDNA 
(bases 2737-3030), provided by Dr. Axel Ullrich (Max Planck In- 
statute, Munich, F.R.G.) :'~2, was prepared as previously described 36. 
Dr. William S. Sly (Was~ington University School of Medicine, St. 
Lou~s, MO) provided the type ILl IGF receptor cDNA 2x. A 377-bp 
BamHI-BamHI fragment: (bases 2958-3335) of type II IGF recep- 
tor cDNA template was prepared as previously described 6. 
E~ch RNA sample (10-.50/~g) was hybridized overnight at 50 °(7, 
v,~th 5 ~ 104 cpm probe lit 30//1 buffer containing 80% formamide, 
40 mM pipegazine-N,N'bis(2-ethanesulfonic acid), 0.4 M NaCI and 
1 mM EDTA. Samples were s~tbsequently digested with 40 pg/ml 
RNase A (Sigma) for 30 rnin at 25 °C. Digestion was terminated 
with proteinase K and SDS. The samples w¢,'e ¢,:~racted with phe- 
nol and then precipitated at -70 °C with 10 ~g tRNA and two vol- 
umes of absolute ethanol. Pellets were res~spended in 5 ?~! , f  80% 
formamide loading buffer and run on a 6% poly~crylamide, 8 M 
urea sequencing gel. Size markers were ~epared by end-labeling 
MspI,cfigested fragment~, of pBR322 (New England Biolabs, Bev- 
erly, MA). The gels were dried and exposed to X-ray film in the 
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Fig. 2. RT-PCR analysis of RNA in cultured human RPE celia;. 
One/tg of total cellular RNA was reverse transcribed followed by 
PCR for 40 cycles with the primers for either IGF I or IGF H. 
Sterile H20 was added instead of RNA in control reactions; all 
other conditions remained constant. The PCR products were sep- 
arated by agarose gel elec~ophoresis and visualized with ethidium 
bronEde. A: the IGF I primers produced the expected 366-bp prod- 
uct in RPE cells and rat liver but not m cc~trol reaction. B: the 
IGF II pn~ers produced the expected 249-bp ~agment in rat mus- 
cle but not in RPE cells. 
presence of an intensifying screen at -70 °C for 1-3 days. 
RESULTS 
IGF gone expression 
We were unable to detect IGF I or IGF Ii mRNA in 
cultured human RPE cells using Northern analysis of 5 
/tg poly(A) + R N A  (results not shown). By RNase pro- 
tection analysis, 30/~g of  total cellular liver RNA Fro- 
tected a 182-bp fragment of the ~GF I exon 3 probe, 
whereas RPE RNA protected no visible fragments (Fig. 
1A). The neuroblas toma cell line SK-N-SH protected a 
580-blp fragment of the 854-bp IGF II probe in RNase 
protection assay (Fig. 1B). This cell line has been d e -  
scribed to expxess large amounts of IGF II mRNA 35. 
The 580-bp protected fragment was smaller than the 
probe because the IGF II transcipt produced by neuro- 
blastoma cell lines does not contain exons 1, 2 and 3 
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Fig. 3. Northern analysis of type I IGF re,~eptor in cultured human 
RPE cells. A: Northern blot of 20/~g tota| RPE RNA. Two tran- 
scipts were detected, one 7-kb and one J l-kb. Thc l l-kb mRNA 
appears to be the major transcript produced by RPE. Radiograph 
exposed 7 days. B: photograph of ethidi~m bromide-stained gel 
from the Northern blot used in (A), showing 28S (5.0-kb) and 18S 
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Fig. 4. A: type I IGF receptor RNase protection assay in cultu~red 
human RPE cells. RPE and MDA-MB231 RNA protected similar 
fragments after hybridization with the 293-bp type I IGF receptor 
probe: a 293.bp fragment, a 200-bp fragment and a 90-bp fragment. 
Radiograph exposed 5 days. B: type II IGF receptor RNase pro- 
tection assay in cultured human RPE cells. The complete 377-bp 
type II IGF receptor probe was p~otected by MDA-MB231 and 
RPE RNA. Radiograpt~ exposed 36 h. 
protect the 854-bp IGF II probe. 
RT-PCR amplified the predicted IGF I 366-bp prod- 
uct from rat liver and RPE RNA but not from the con- 
trol water sample (Fig. 2A). The expected IGF II 249-bp 
product was amplified in rat muscle but not in RPE (Fig. 
2B) or a control water samp!e (results not shown). 
1GF receptor gene expression 
Northern hybridization of total RNA (20/~g) with a 
32p-labelled 1247-bp cDNA probe for type I IGF recep- 
tor detected 7-kb and 11-kb transcripts in RPE (Fig. 3A, 
B). The ll-kb hybridization band was of higher inten- 
sity than the 7-kb band, suggesting that the ll-kb mRNA 
is the major transcript produced by RPE. In RNase pro- 
tection analysis experiments, RPE RNA protected three 
fragments of the 293-bp type I IGF receptor cDNA (Fig. 
4A). MDA-MB231 RNA protected these same three 
fragments of the 293-bp type I IGF receptor cDNA: the 
complete 293-bp fiagment, a 200-bp fragment end an 
90-bp fragment. This pattern of expression results from 
alternative splicing of tt~e type I IGF receptor gene 36. 
RPE RNA also protected the complete 377-bp BamHI- 
BamHI fragment oi type ii IGF receptor probe (Fig. 
4B). The les~ intense, smaller bands are due to the hy- 
bridization between sample RNA and fragments of ribo- 
probe synthesized at less than full template length. These 
bands represent, therefore, an artifact of incomplete 
probe synthesis and not unique cellular RNAs. 
DISCUSSION 
The purpose of this study was to determine if cultured 
human RPE cells express the genes for IGF I and II a~,d 
their corresponding receptors. We found low levels of 
IGF I gene expression detectable only by RT-PCR and 
not by RNase protection or Northern blotting. Further 
investigation will be required to prove that these tran- 
scripts are translated into IGF I peptide, but the pres- 
ence of IGF I mRNA transcripts argues for endogenous 
IGF I production. The presence of RPE IGF I immu- 
noreactivity both in vitro and in vivo support this tenet 34. 
In contrast to IGF I, type I IGF receptor mRNA was 
detected both by Northern blotting and RNase protec- 
tion. Because Northern analysis is 100-fold less sensitive 
than RNase protection 26, which in turn is less sensitive 
than RT-PCR ~7, our data suggest that type I IGF recep- 
tor mRNA is more abundant in cultured human RPE 
cells than IGF I mRNA (detectable only by RT-PCR). 
Northern analysis for the type I IGF receptor revealed 
7-kb and l l-kb mRNA transcripts in RPE. This tran- 
script profile is identical to the original hybridization pat- 
tern reported by Ullrich and coworkers in 3T3-LI fibro- 
blasts and adipocytes 32. RNase protection of RPE RNA 
for the type I IGF receptor protected three fragments: 
293 bp, 200 bp and 90 bp. This protection pattern has 
been reported in the breast cancer cell line MDA-MB 
231 where neither increasing amounts of RNase nor 
changing the time or temperature of the RNase diges- 
tion had an effect on the three fragments and is due to 
alternative splicing of the type I IGF receptor gene 36. 
Co-expression of IGF I and IGF I receptor genes by 
cultured RPE cells suggests at, autocrine role for IGF I 
on RPE~ IGF I, acting t~rough its receptor, may serve 
as a survival factor for human RPE in vitro, s~milar to 
the role of basic fibroblast growth factor in maintaining 
photoreceptors ~J. IGF I may represent one of the active 
factors present in RPE-conditioned medium, which stim- 
ulates photoreceptor differentiation and Mfiller cell pro- 
life~ation 3°. Alternatively, the low level of gene expres- 
sion of IGF  1 compared to the type I IGF receptor may 
imply a paracrine role for circulating IGF I. In retinal 
endothelial cells, binding of circulating IGF I increases 
DNA synthesis and regulates endothelial cell chemo- 
taxis ts'~9. Additional experiments examining IGF I 
mRNA translation into protein may clarify the primary 
mode of action of IGF I in RPE. 
We found no IGF II gene expression in cultured hu- 
man RPE cells. While present in fetal sclera and cor- 
nea t3, no adult ocular source has been reported 27, sug- 
gesting that adult vitreal IGF II immunoreactivity arises 
from circulating IGF II n .  Human cultured RPE cells 
synthesized m R N A  for the type II IGF receptor, sup- 
porting the report of Ocrant and coworke~s of substan- 
tial levels of type II IGF receptor immunoreactivity in 
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